MedWatch

Lundbeckfonden takes former Novo-boss' biotech baby under its wing

A new drug at Novo Nordisk's lab sparked such big interest for Rasmus Jørgensen that he decided to leave the diabetes giant and build his own biotech firm from it. Now Lundbeckfonden will help him find the money.

Photo: PRIVATE PHOTO

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles